294 related articles for article (PubMed ID: 16373240)
1. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
Edwards JB
Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
3. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
4. Fecal occult blood testing: clinical value and limitations.
Simon JB
Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
[TBL] [Abstract][Full Text] [Related]
5. [Colorectal cancer screening is profitable].
Pikkarainen P
Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
[No Abstract] [Full Text] [Related]
6. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
Trojan J; Povse N; Schröder O; Stein J
Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
[TBL] [Abstract][Full Text] [Related]
7. Fast track referrals for colorectal cancer: the impact of the faecal occult blood test screening programme.
Ward N; Wright J; Marsh S; Norton J
Colorectal Dis; 2007 Mar; 9(3):258-61. PubMed ID: 17298625
[No Abstract] [Full Text] [Related]
8. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
van Veen W; Mali WP
Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
[TBL] [Abstract][Full Text] [Related]
9. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
Skitek M
Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
[No Abstract] [Full Text] [Related]
10. A comparison of three stool tests for colorectal cancer screening.
Greenwald B
Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
[TBL] [Abstract][Full Text] [Related]
11. [Faecal occult blood test and mass screening for colorectal cancer].
Hiwatashi N; Shimada T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
[No Abstract] [Full Text] [Related]
12. [Arguments against implementing a population-based screening programme for colorectal cancer].
Bonneux L
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
[TBL] [Abstract][Full Text] [Related]
13. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
Saito H
J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening.
Cher DJ
J Public Health Med; 1993 Jun; 15(2):211-2. PubMed ID: 8353013
[No Abstract] [Full Text] [Related]
16. Cost-effective screening strategies for colorectal cancer.
Whynes DK; Walker AR; Hardcastle JD
J Public Health Med; 1992 Mar; 14(1):43-9. PubMed ID: 1599742
[TBL] [Abstract][Full Text] [Related]
17. Experiences in providing a screening service for colorectal cancer from a pathology laboratory.
Edwards JE; Williams JA; Thomas DW
Pathology; 2004 Aug; 36(4):330-4. PubMed ID: 15370132
[TBL] [Abstract][Full Text] [Related]
18. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
19. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
20. Role of fecal occult-blood testing.
Bond JH; Mandel JS; Church TR
N Engl J Med; 1998 Sep; 339(11):774-5. PubMed ID: 9742033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
